Qualyst Transporter Solutions Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
Qualyst Transporter Solutions General Information
Description
Provider of hepatic drug transporter products and contract research services designed to predict clinically relevant drug interactions. The company's B-CLEAR technology when applied to properly functioning hepatocytes in culture, opens the bile pockets, analogous to bile canaliculi, allowing the measurement of material that has been transported from inside the cell, enabling clinicians to submit regulatory FDA in support of mechanisms of transporter interactions and hepatotoxicity.
Contact Information
Website
www.qualyst.com
Formerly Known As
Qualyst
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 2810 Meridian Parkway
- Suite 100
- Durham, NC 27713
- United States
Qualyst Transporter Solutions Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Qualyst Transporter Solutions Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of hepatic drug transporter products and contract research services designed to predict clinically relevant dru
Drug Delivery
Durham, NC
11
As of 2015
00.00
000000000000
00.00
000000
d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000 000000000
New York, NY
00
As of 0000
000.00
0000000000
000.00
Add Comparison
Qualyst Transporter Solutions Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00000000 000000000 | Formerly VC-backed | New York, NY | 00 | 000.00 | 0000000000 | 000.00 |
Qualyst Transporter Solutions Patents
Qualyst Transporter Solutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017329025-A1 | Methods and systems for screening candidate compounds for their potential to cause systemic or hepatic toxicity | Pending | 16-Sep-2016 | 00000000000 | |
| CA-3036704-A1 | Methods and systems for screening candidate compounds for their potential to cause systemic or hepatic toxicity | Pending | 16-Sep-2016 | 00000000000 | |
| EP-3513194-A4 | Methods and systems for screening candidate compounds for their potential to cause systemic or hepatic toxicity | Active | 16-Sep-2016 | 00000000000 | |
| EP-3513194-B1 | Methods and systems for screening candidate compounds for their potential to cause systemic or hepatic toxicity | Active | 16-Sep-2016 | 00000000000 | |
| EP-4109102-A1 | Methods and systems for screening candidate compounds for their potential to cause systemic or hepatic toxicity | Pending | 16-Sep-2016 | G01N33/5014 |
Qualyst Transporter Solutions Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
